LifeCell alleges Integra writ's timing was malicious
This article was originally published in Clinica
Executive Summary
LifeCell claims that Integra's filing of a patent infringement suit while it was in the middle of a public share offering was an intentional plan to damage the company. In response to its rival's patent suit, the artificial skin developer has now filed for tortious interference.